GL1X · GenesisL1 explorer

MolNFT v1 · #48908 · protein

The androgen receptor prostate cancer mutant H874Y ligand binding domain bound with testosterone and an ar 20-30 peptide

2Q7K: “The androgen receptor prostate cancer mutant H874Y ligand binding domain bound with testosterone and an ar…”. X-ray diffraction, 2 ligands (TES, SO4), 2 pockets (best druggability 0.83). MolNFT v1 #48908 on GenesisL1: 3D structure…

PDB
2Q7K
Type
protein
Length
252 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Androgen receptor
UniProt
P10275
Ligands
TES, SO4
Pockets
2 · best druggability 0.83

Structure

x-ray diffraction · 2 distinct chains · 69% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAndrogen receptorprotein24269% helix, 5% strandP10275
BAndrogen receptorprotein1080% helix, 0% strandP10275

Ligands and binding sites

  • TES · Testosterone · ligand · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11630.830.9822TES
21400.620.8525GOL

Interfaces

1 interface between chains.

  • A–B · 513 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 2Q7K · The Androgen Receptor Prostate Cancer Mutant H874Y Ligand Binding Domain Bound with… · the same entry in another collection · chain A against A, TM-score 1.00
  • P10275 · AlphaFold monomer V2.0 prediction for androgen receptor (P10275) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.